Abstract:OBJECTIVE:To explore the feasibility of IGF2 imprinting system in target gene therapy for tumors.METHODS:The mouse H19 enhancer, DMD and promoter H19 were amplified by PCR from mouse genomic DNA and then cloned into the plasmid pDC312. The EGFP and DT-A fragments were amplified by PCR and cloned into the recombinant plasmid, and then the shuttle plasmid were transfected into HEK293 cells together with the adenoviral vector Ad5, namely, Ad-EGFP and Ad-DT-A. Adenovirus hexon gene expression was applied to confirm the presence of adenovirus infections. The effect of the IGF2 imprinting system was tested by fluorescence microscopy. RT-PCR and Western blotting after transfection of the recombinant adenoviral vectors into cancer cells were used to show loss of IGF2 imprinting (LOI) and maintenance of IGF2 imprinting (MOI), respectively. The anti-tumor effect was assessed by MTT and flow cytometry after the HCT-8 (LOI). Human breast cancer cell line MCF-7 (MOI) and human normal gastric epithelial GES-1 (MOI) cell line were transfected with Ad-DT-A in vitro. The anti-tumor effect was detected by injecting the Ad-DT-A in nude mice carrying HCT-8 tumors.RESULTS:The expression of EGFP protein, DT-A mRNA and DT-A protein were seen to be positive only in the HCT-8 tumor cell line. Infection with Ad-DT-A resulted in obviously growth inhibition in HCT-8 cells (75.4 ± 6.4)% compared with that in the control group, and increased the percentage of apoptosis in the HCT-8 cells (20.8 ± 5.9)%. The anti-tumor effect was further confirmed by injecting the recombinant adenoviruses in HCT-8 tumor-bearing nude mice, and the results showed that the Ad-DT-A inhibited the tumor growth, with on inhibition rate of 36.4%.CONCLUSIONS:The recombinant adenoviruses carrying IGF2 imprinting system and DT-A gene have been successfully constructed, while Ad-DT-A can effectively kill the tumor cells showing loss of IGF2 imprinting. It might play an important role in future target gene therapy against malignant tumors based on loss of IGF2 imprinting.

[Effect of Recombinant Adenovirus Ad-DT-A in Targeted Therapy for Malignant Cancer Cell Lines with Loss of IGF2 Imprinting].

Targeted therapy for malignant cancer mediated by adenovirus vector expressing diphtheria toxin a based on loss of IGF2 imprinting

Targeted tumor gene therapy based on loss of IGF2 imprinting.

Gene Therapy for Cancer Through Adenovirus Vector-Mediated Expression of the Ad5 Early Region Gene 1A Based on Loss of IGF2 Imprinting

Gene Therapy for Human Colorectal Cancer Cell Lines with Recombinant Adenovirus 5 Based on Loss of the Insulin-Like Growth Factor 2 Imprinting.

Gene Therapy for Colorectal Cancer by an Oncolytic Adenovirus That Targets Loss of the Insulin-Like Growth Factor 2 Imprinting System

Construction and identification of recombinant adenovirus carrying IGF2 imprinting system

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.

Tetracycline controlled DT/VEGF system gene therapy mediated by adenovirus vector

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Gene Therapy For Colorectal Cancer By Adenovirus-Mediated Sirna Targeting Cd147 Based On Loss Of The Igf2 Imprinting System

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity

Augmentation of Antitumor Effect of Adenovirus-Mediated CD Suicide Gene Therapy by Cotransfer of Interleukin 2 Gene in Melanoma-Bearing Mice.

Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism]

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector

[Gene Expression of Tumor Cells Both in Vitro and in Vivo Enhanced by Integrin-Targeting Adenovirus Vector].